↓ Skip to main content

Dove Medical Press

Article Metrics

Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin…

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, September 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
59 Mendeley
Title
Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin
Published in
ClinicoEconomics and Outcomes Research: CEOR, September 2013
DOI 10.2147/ceor.s46991
Pubmed ID
Authors

Dipen Patel, Jennifer Stephens, Xin Gao, Verheggen, Ahmed Shelbaya, Seema Haider

Abstract

Previous economic analyses evaluating treatment of methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft-tissue infections (cSSTI) failed to include all direct treatment costs such as outpatient parenteral antibiotic therapy (OPAT). Our objective was to develop an economic model from a US payer perspective that includes all direct inpatient and outpatient costs incurred by patients with MRSA cSSTI receiving linezolid, vancomycin, or daptomycin.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 3%
Brazil 2 3%
Australia 1 2%
China 1 2%
Unknown 53 90%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 17%
Researcher 9 15%
Other 8 14%
Student > Bachelor 6 10%
Student > Postgraduate 6 10%
Other 13 22%
Unknown 7 12%
Readers by discipline Count As %
Medicine and Dentistry 21 36%
Agricultural and Biological Sciences 7 12%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Social Sciences 4 7%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 11 19%
Unknown 9 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2013.
All research outputs
#8,849,149
of 14,123,042 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#247
of 369 outputs
Outputs of similar age
#69,768
of 132,131 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#11
of 13 outputs
Altmetric has tracked 14,123,042 research outputs across all sources so far. This one is in the 24th percentile – i.e., 24% of other outputs scored the same or lower than it.
So far Altmetric has tracked 369 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 132,131 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.